» Articles » PMID: 19015066

Origin of Renal Cell Carcinomas

Overview
Specialty Oncology
Date 2008 Nov 19
PMID 19015066
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a heritable disorder of somatic cells: environment and heredity are both important in the carcinogenic process. The primal force is the "two hits" of Knudson's hypothesis, which has proved true for many tumours, including renal cell carcinoma. Knudson et al. [1, 2] recognised that familial forms of cancer might hold the key to the identification of important regulatory elements known as tumour-suppressor genes. Their observations (i.e., that retinoblastoma tend to be multifocal in familial cases and unifocal in sporadic presentation) led them to propose a two-hit theory of carcinogenesis. Furthermore, Knudson postulated that patients with the familial form of the cancer would be born with one mutant allele and that all cells in that organ or tissue would be at risk, accounting for early onset and the multifocal nature of the disease. In contrast, sporadic tumours would develop only if a mutation occurred in both alleles within the same cell, and, as each event would be expected to occur with low frequency, most tumours would develop late in life and in a unifocal manner [3, 4]. The kidney is affected in a variety of inherited cancer syndromes. For most of them, both the oncogene/tumour-suppressor gene involved and the respective germline mutations have been identified. Each of the inherited syndromes predisposes to distinct types of renal carcinoma. Families with hereditary predisposition to cancer continue to provide a unique opportunity for the identification and characterisation of genes involved in carcinogenesis. A surprising number of genetic syndromes predispose to the development of renal cell carcinoma, and genes associated with five of these syndromes have been already identified: VHL, MET, FH, BHD and HRPT2. Few cancers have as many different types of genetic predisposition as renal cancer, although to date only a small proportion of renal cell cancers can be explained by genetic predisposition.

Citing Articles

Genetically transitional disease: conceptual understanding and applicability to rheumatic disease.

Niewold T, Aksentijevich I, Gorevic P, Gibson G, Yao Q Nat Rev Rheumatol. 2024; 20(5):301-310.

PMID: 38418715 DOI: 10.1038/s41584-024-01086-9.


Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion.

Lee M, Ham N, Hwang C, Jang J, Lee B, Jeong J Int J Mol Sci. 2022; 23(17).

PMID: 36077072 PMC: 9456023. DOI: 10.3390/ijms23179675.


Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.

Osca-Verdegal R, Beltran-Garcia J, Gorriz J, Jabaloyas J, Pallardo F, Garcia-Gimenez J Front Cell Dev Biol. 2022; 10:879814.

PMID: 35813211 PMC: 9257016. DOI: 10.3389/fcell.2022.879814.


Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?.

Trevisani F, Floris M, Vago R, Minnei R, Cinque A Cells. 2022; 11(10).

PMID: 35626699 PMC: 9139553. DOI: 10.3390/cells11101658.


Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.

Jorge S, Capelo J, LaFramboise W, Satturwar S, Korentzelos D, Bastacky S BMC Med. 2021; 19(1):196.

PMID: 34482820 PMC: 8420025. DOI: 10.1186/s12916-021-02071-9.


References
1.
Chu P, Weiss L . Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology. 2001; 39(5):455-62. DOI: 10.1046/j.1365-2559.2001.01273.x. View

2.
Antonelli A, Portesi E, Cozzoli A, Zanotelli T, Tardanico R, Balzarini P . The collecting duct carcinoma of the kidney: a cytogenetical study. Eur Urol. 2003; 43(6):680-5. DOI: 10.1016/s0302-2838(03)00152-0. View

3.
Weidner U, Peter S, Strohmeyer T, Hussnatter R, Ackermann R, Sies H . Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res. 1990; 50(15):4504-9. View

4.
Ishikawa I, Kovacs G . High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology. 1993; 22(2):135-9. DOI: 10.1111/j.1365-2559.1993.tb00091.x. View

5.
Kenck C, Bugert P, Wilhelm M, Kovacs G . Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas. Oncogene. 1997; 14(9):1093-8. DOI: 10.1038/sj.onc.1200915. View